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Introduction
Besides being a source of energy and a structural compo-
nent of the cell wall, carbohydrates also mediate various rec-
ognition processes when attached to proteins or lipids.[1]
Well-known carbohydrate motifs of such glycoconjugates
are the cancer epitope Sialyl Lewis X and the AB0 blood
group determinants. In addition, glycosylation is an impor-
tant source of structural diversity of natural products, such
as alkaloids, steroids, flavonoids, and antibiotics. Glycosides
typically display properties that differ from those of their
non-glycosylated aglycons.[2] A prime example is naringin, a
flavanone glycoside that is responsible for the bitter taste of
citrus fruits. Removal of the glycon part eliminates the
bitter taste, which is one of the main goals of enzymatic
treatment of grapefruit juice.[3] The opposite is true for gly-
cirrhizin, a terpenoid glycoside from sweetwood (Glycirhyza
glabra) that loses most of its sweetness upon hydrolysis.[4]
Since the transfer of a glycosyl group can influence both
the physicochemical and biological properties of an organic
molecule, such processes may be used for a wide range of
applications. The most obvious advantage of introducing a
carbohydrate moiety is the increased solubility of hydropho-
bic compounds. This is nicely illustrated in flavonoids, the
pharmaceutical properties of which can often be efficiently
exploited only in the form of their hydrophilic glycosyl de-
rivatives.[2] Glycosylation may also be used to improve the
stability of labile molecules. A famous example is ascorbic
acid, a very sensitive vitamin, the long-term storage of
which can be drastically extended by glycosylation, resulting
in high-value applications in cosmetics and tissue culturing.[5]
Another important application of glycosylation is the reduc-
tion of skin irritation caused by hydroquinone, employed in
cosmetics for its skin whitening effect.[6] Glycosides of fla-
vors and fragrances, in turn, can function as controlled re-
lease compounds. The a-glucoside of l-menthol, for exam-
ple, is only slowly hydrolyzed in the mouth, resulting in a
prolonged sensation of freshness.[7] Last but not least, it has
been possible to modulate the activity spectrum of glyco-
peptide antibiotics by varying their carbohydrate moiety, in
a process known as “glycorandomization”.[8,9]
In view of these examples, the development of cheap and
efficient glycosylation technologies, useful both in the labo-
ratory and in industry, is highly desirable. In this review, the
challenges and recent innovations concerning the glycosyla-
tion of small, non-carbohydrate molecules are covered.
Chemical versus Enzymatic Glycosylation
Glycosylation reactions by conventional chemical synthesis
are used intensively in the field of glycochemistry. Despite
the variety of glycosylation protocols developed to date,[10–25]
synthesis of glycosylated compounds largely relies on four
non-enzymatic reactions (Scheme 1). One of the first was fa-
mously developed by Koenigs and Knorr, in which glycosyl
halides, activated with silver salts, are used as glycosyl
donors.[26–28] Glycosyl trichloroacetimidates were later found
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to be very powerful donor substrates with an excellent leav-
ing group.[29] Alternatively, more stable glycosides, such as
thioglycosides and n-pentenyl glycosides, can be used when
activated by electrophilic reagents.[30] There are, however,
two major issues connected with the outcome of these reac-
tions, that is, the regioselectivity and the configuration of
the glycosidic linkage. The former can be solved by appro-
priate protection strategies, whereas the latter is strongly de-
pendent on the neighboring group participation of the C2
substituent. Additionally, solvents and catalysts have an im-
portant effect on the anomeric outcome of glycosylation re-
actions.
The chemical methods suffer from a number of draw-
backs: labor-intensive activation and protection procedures,
multistep synthetic routes with low overall yields, the use of
toxic catalysts and solvents and the amount of waste.[31] To
overcome these limitations, specific enzymes may be used
for the synthesis of glycosides. DeRoode et al. have calculat-
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ed that enzymatic glycosylation reactions generate fivefold
less waste and have a 15-fold higher space–time yield, a tre-
mendous improvement in eco-efficiency.[32] Although oligo-
saccharides, such as isomaltulose, isomalto (IMO), galacto
(GOS) and fructo oligosaccharides (FOS), are synthesized
industrially with the use of enzymes,[33–35] this is not yet the
case for glycosides. A perspective on the enzymatic glycosy-
lation of small organic molecules will, therefore, be present-
ed in this review.
Several types of carbohydrate-active enzymes (CAZymes)
may be used in glycosylation reactions, each with specific
characteristics (Scheme 2).[36,37] Natures catalysts for glyco-
sylation reactions are known as “Leloir” glycosyl transferas-
es (GT). Although very efficient, these enzymes require ex-
pensive nucleotide-activated sugars (e.g., uridine diphos-
phate glucose) as glycosyl donors, which hampers their ap-
plication in the laboratory and industry. However, two spe-
cial types of glycosyl transferring enzymes are the
proverbial “exception to the rule” and are active with low-
cost donors. Glycoside phosphorylases (GP), on the one
hand, only require glycosyl phosphates (e.g., glucose-1-phos-
phate) as donors—compounds that can easily be obtained in
large quantities.[38] Transglycosidases (TG), on the other
hand, even employ non-activated carbohydrates (e.g., su-
crose) for the transfer of a glycosyl group.[39] Additionally,
glycoside hydrolases (GH) can also be used for synthetic
purposes when applied under either kinetic (transglycosyla-
tion) or thermodynamic (reverse hydrolysis) control.[40] In
the following sections, the glycosylation reactions catalyzed
by GH, GP, and TG will be described in more detail.
Glycoside Hydrolases
Glycosidases (O-glycoside hydrolases; EC 3.2.1.-) are in
vivo purely hydrolytic enzymes. Their subclass in the
IUBMB system (International Union of Biochemistry and
Molecular Biology) comprises over 150 entries. In the
CAZy database (Carbohydrate Active Enzymes, http://
www.cazy.org/) glycosidases are structurally divided into
over 130 families.[42]
Glycosidases split saccharidic chains by transferring the
cleaved glycosyl moiety to water as an acceptor substrate
(Scheme 3). In laboratory conditions, however, the acceptor
molecule may be virtually any structure possessing a hydrox-
yl group, allowing the formation of a new glycosidic bond,
instead of the naturally occurring hydrolysis reaction. Two
strategies for such synthetic processes may be applied. First,
two reducing sugars react in a thermodynamically controlled
condensation process, usually called “reverse hydrolysis”.
This approach has been preferentially used for the glycosy-
lation of alcohols.[43] Besides primary and secondary alco-
hols, successful glycosylations of sterically hindered tertiary
alcohols were accomplished, such as of 2-methylbutan-2-ol,
2-methylpentan-2-ol or tert-butyl alcohol.[44, 45] More complex
structures are efficiently glycosylated under kinetic control
in so-called transglycosylation reactions. In this case, glyco-
side donors require activation by a good leaving group; this
Scheme 2. Glycosylation reactions catalyzed by the various classes of car-
bohydrate-active enzymes (Copyright Wiley-VCH Verlag GmbH & Co.
KGaA. Adapted and reproduced with permission from reference [41]).
Scheme 1. Prominent glycosyl donors used in chemical synthesis (Ac=
Acetyl, NBS=N-bromosuccinimide).[30]
Scheme 3. Synthetic and hydrolytic reactions catalyzed by glycosidases.
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may be an aromatic structure such as nitrophenyl, methyl-
umbelliferyl, fluorides, azides, and oxazolines. Thereby, gly-
cosyl oxazolines mimic reaction intermediates during the
cleavage of hexosamine substrates.[46] During the cleavage of
activated donors, the leaving group is released and the inter-
action with an acceptor proceeds at the activated anomeric
center. Transglycosylations afford higher yields of 20–40%
but exceptions of even 80% isolated yield have been report-
ed.[47] Interestingly, the transglycosylation mode can only be
applied with retaining glycosidases (i.e., the glycosidic prod-
uct has the same anomeric configuration as the substrate en-
tering the hydrolytic reaction). In the last 100 years, glycosi-
dase-catalyzed synthesis has developed from simple glycosy-
lations of alcohols to one-pot multienzyme processes,[48] tail-
ored enzyme mutants,[49] and boldly derivatized substrates as
building blocks of saccharides with direct medicinal or bio-
technological applications.[50] Glycosidase-assisted synthesis
and mechanisms have recently been examined in several re-
views.[51–54]
It is to be emphasized that an important aspect of the in-
dustrial application of glycosidases consists in targeted trim-
ming of long, natural polysaccharide chains, thus producing
either the desired small active compound directly or embod-
ied in a set of defined derivatives of increasing molecular
weight (e.g., di-, tri-, tetrasaccharides, etc.). Thus, a high-
mannose oligosaccharide was selectively trimmed by various
glycosidases to yield a library of carbohydrate compounds.[55]
Another use is the targeted degradation of plant material,
such as of lignocellulose,[56] arabinoxylan[57] or lignin-con-
taining polymeric feedstock.[58]
The food, cosmetics, and fine chemicals industries repre-
sent the major large-scale applications of glycosidases. His-
torically, processes involving starch manipulation, milk treat-
ment (sweetness, lactose-free formulas etc.), brewery, and
wine industry comprise the typical uses of glycosidases.
Other examples include the enzymatic processing of cereal
products using cellobiase, exo-1,4-glucosidase, mannase, and
xylanase.[59] Another important area is the production of
non-digestible galactooligosaccharides (GOS) of prebiotic
nature. Here, lactose from various sources is treated with
whole cells of Bifidobacterium bifidum, which contain cell-
bound b-galactosidases.[60] Improvement and refinement of
tea flavor has also been accomplished by using various gly-
cosidases.[61] Furthermore, through the trimming action of b-
galactosidases and b-xylosidases, the antioxidant kaempfer-
ol-3-O-rutinoside can be prepared from green tea seeds.[62]
Similarly, the derhamnosylated or deglucosylated flavonoid
icariin is gained through enzymatic trimming as an anti-
ageing, anti-wrinkling, and whitening agent for cosmetic
preparations.[63] Flavonoids, such as hesperidin, naringin or
quercetin which are used as anti-oxidants and nutraceuticals,
are often glycosylated to increase their water solubility and
thus absorbability.[64]
Glycosidases are characterized by robustness, stability, ab-
solute stereoselectivity, and broad substrate specificity.
These properties predestine them to numerous uses, espe-
cially when reactive or sensitive substrates are involved that
require mild reaction conditions. Moreover, the resulting
products may be usable in medicinal, pharmaceutical, or nu-
traceutical fields, since they do not generally encounter any
harsh reagents in the glycosylation process.[65, 66] Two major
issues may need to be overcome when glycosidases are used
in the synthetic mode: low regioselectivity leading to mix-
tures of glycosylated products, and yields that are far from
quantitative. Various reaction set-ups have been employed
in glycosidase-assisted synthesis to diminish water activity,
increase reaction yields, and/or optimize reaction outcome.
These include solid-phase synthesis,[67] reactions in ionic liq-
uids,[68] inorganic solvents,[69] microwave irradiation,[43,70] or
various supporting additives, such as salts and cyclodex-
trins.[71] Although these attempts have shown promising re-
sults, the focus and future of glycosidase catalysis rather lies
in ingenious combinations of donor–acceptor–catalyst in
aqueous solution. Moreover, such alternative methods are
not accepted in the food and cosmetics industries, for which
water is the only possible solvent in order to eliminate the
potential risks of toxicity.
The most intensively expanding field in glycosidase-cata-
lyzed synthesis is that of enzyme engineering. This relatively
young discipline allows construction of glycosidase variants
with improved properties, either by site-directed mutagene-
sis of catalytic residues (well-known glycosynthases) or by
randomly introduced mutations through directed evolu-
tion.[72,73] The development of glycosynthase variants from
inverting glycosidases, such as the exo-b-oligoxylanase from
Bacillus halodurans[74,75] and the 1,2-a-l-fucosidase from Bi-
fidobacterium bifidum,[76] represents an important break-
through because the respective wild-type enzymes are natu-
rally incapable of catalyzing transglycosylation reactions.
Another crucial finding is the design of first-generation gly-
cosynthases exercising a substrate-assisted catalytic mecha-
nism. These mutants utilize oxazoline donors mimicking the
intermediate of the catalytic process, either by mutating the
acid/base residue[77,78] according to the classical glycosyn-
thase pattern or by mutating the water-stabilizing residue
similarly to inverting glycosynthases.[77]
Recently, two glycosynthases derived from retaining a-l-
fucosidases were added to the glycosynthase family.[79] This
is only the third example of a-glycosynthases, after those of
a retaining a-glucosidase[80] and an inverting a-l-fucosi-
dase.[76] Notably, the a-fucosynthases were able to process b-
l-fucosyl azides as glycosyl donors, instead of the generally
used fluorides. The concept of glycosyl azides as donors for
glycosidases was previously applied with a range of natural
glycosidases[81,82] and also with thioglycoligases.[83] The thio-
glycoligase enzymes, together with double mutant thioglyco-
synthases,[84] are the first biocatalysts readily synthesizing
thioglycosides with good yields, up to 50%. Glycosyl azides
are an especially valuable alternative when the respective
fluoride donors lack sufficient stability, such as in the case
of N-acetyl-b-d-hexosaminyl fluorides or b-l-fucosyl fluo-
rides. Their efficient application in glycosynthase-catalyzed
synthesis opens a new direction in expanding the repertoire
of glycosynthases.
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An industrially applicable synthesis using a glycosynthase
derived from Rhodococcus endoglycoceramidase affords
various gangliosides in nearly quantitative yields, on a scale
up to 300 mg.[85] New catalysts with substantially increased
catalytic efficiency were also created by directed evolution
approach, based on the design of an efficient high-through-
put screening method. The validity of this approach was
shown for example in thermophilic b-xylosynthase[86] and b-
glycosynthase.[87] Interestingly, some glycosynthase variants
were found to display activity towards acceptors that are not
part of their normal substrate. The E197S variant of the cel-
lulase Cel7B from H. insolens, for example, is able to effi-
ciently glycosylate flavonoid compounds, with reaction rates
that are comparable with those of natural Leloir transferases
and with a preparative yield of about 85% (Scheme 4).[88]
Transglycosidases
Transglycosidases are basically retaining glycosidases that
are able to avoid water as an acceptor substrate during the
interconversion of carbohydrate chains.[36] However, they
also display low activity towards non-carbohydrate acceptor
substrates, which can be exploited for the synthesis of glyco-
sylated products in vitro. One example is the enzyme cyclo-
dextrin glucanotransferase (CGTase), catalyzing synthesis of
cyclodextrins and maltodextrins,[89] but also a broad range of
glucosylation reactions with acceptor substrates, using starch
as donor substrate.[90,91] High-resolution crystal structures of
CGTase proteins, and biochemical characteristics of many
CGTase mutants, have provided clear insights in the role of
specific amino acid residues in the CGTase active site for
proper binding of acceptor substrates in glucosylation reac-
tions.[91, 92] A particularly interesting example of a CGTase-
catalyzed glucosylation reaction is that of resveratrol, a com-
pound possessing antioxidant, anti-inflammatory, estrogenic,
anticancer, cardioprotective, neuroprotective, and immuno-
modulatory bioactivities.[93] CGTase of Thermoanaerobacter
sp. converted resveratrol into a-glucosylated products,
reaching 50% conversion. The water solubilities of these
glucosylated derivatives were at least 65-fold higher than
that of resveratrol.[93,94] It is expected that this modification
of physicochemical properties (solubility, but also partition
coefficient) by glucosylation exerts a positive effect on the
bioavailability of these compounds.
Interestingly, several transglycosidases employ sucrose as
donor substrate, a very reactive molecule that allows yields
to be obtained comparable with those of the nucleotide-acti-
vated donors of Leloir transferases.[95] Although the specific-
ity of these sucrase-type enzymes is rather limited, the low
cost of their glycosyl donor is a major advantage for indus-
trial applications. Transglycosylation reactions with sucrose
have already been exploited for the large-scale production
of various oligosaccharides. Sucrose mutase, for example, is
employed as a whole-cell biocatalyst for the production of
isomaltulose, a non-cariogenic and low-glycemic sweetener
for use in beverages and food preparations
(Scheme 5).[33,96,97] In turn, fructo-oligosaccharides (FOS)
can be produced from sucrose with the help of fructansu-
crase enzymes.[98,99] Interestingly, the range of products that
can be synthesized with fructansucrases has been extended
by the development of sucrose analogues, activated sub-
strates that contain monosaccharides other than glucose and
fructose.[100] In this review, however, the focus will be on glu-
cansucrase enzymes that transfer the glucosyl rather than
the fructosyl moiety of sucrose.
Glucansucrases are extracellular enzymes, only reported
to occur in lactic acid bacteria, members of the genera Leu-
conostoc, Streptococcus, Lactobacillus, and Weissella.[101–103]
Their major activity is to convert sucrose into a-glucan poly-
saccharides (Scheme 6), most abundantly with a-1,6-glycosi-
dic linkages (Leuconostoc dextransucrase). Additional free
hydroxyl-groups, however, exist on a glucose unit, and in
more recent years it has become apparent that all other pos-
sible glycosidic linkages naturally occur in the a-glucan
products of glucansucrase enzymes from various bacteria.
Examples are mutan with a-1,3-linkages (Streptococcus mu-
tansucrase)[104] and alternan with alternating a-1,3- and a-
1,6-linkages (Leuconostoc alternansucrase).[105] Also a glu-
cansucrase enzyme synthesizing a-1,2-linkages has been re-
ported, again from a Leuconostoc strain.[106] More recently,
we have characterized reuteran as a glucan with a-1,4-link-
ages, always occurring in a mixture with a-1,6-linkages (Lac-
tobacillus reuteri reuteransucrase)[107–109] and a glucansucrase
enzyme that cleaves a-1,4-linkages (e.g., in maltodextrins)
Scheme 4. The glycosynthase E197S variant of cellulase Cel7B displays activity towards flavonoid acceptors, which are not part of its normal substrate.[88]
Scheme 5. The transglycosylation of sucrose (a-1,2-bond) with the
enzyme sucrose mutase mainly yields isomaltulose (a-1,6-bond), with
20% trehalulose (a-1,1-bond) as contaminating product.[34]
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and introduces a-1,6-linkages.[110–112] These glucansucrase en-
zymes strongly differ in reaction specificity, introducing dif-
ferent glycosidic linkages in their glucan products. They also
differ in the degree and type of branching, and in the molec-
ular mass of their glucan products. The recent identification
of glucansucrase enzymes in the genus Weissella[113] suggests
that these enzymes occur more widespread in nature, al-
though their distribution at present remains limited to lactic
acid bacteria.
Glucansucrase enzymes have been classified in glycoside
hydrolase family GH-70 (http://www.cazy.org) on the basis
of four catalytically important conserved sequence motifs
that are similar to those of members of glycoside hydrolase
families GH-13 and GH-77, but which occur in a different
order. This has led to the proposal that glucansucrases
belong to the a-amylase superfamily (or GH-H clan), but
have a circularly permuted (b/a)8-barrel as catalytic
domain.[114] However, glucansucrases are much larger en-
zymes (1600–1800 amino acid residues) than their GH-13
and GH-77 relatives (500–600 amino acids), and contain an
N-terminal domain of variable length and unknown function
and a C-terminal, putative glucan-binding domain flanking
the central catalytic domain.[101] By analyzing glucansucrase
site-directed mutants and hybrid glucansucrase proteins, we
have identified active site amino acid residues that deter-
mine the specificity of the glycosidic linkage. This has al-
lowed the synthesis of novel a-glucans with strongly varying
glycosidic linkage ratios, and even of unnatural glucans with
mixtures of a-1,3- and a-1,4- and a-1,6-linkages[115–117] that
have been subjected to a detailed structural characteriza-
tion.[118,119]
Recently, Dijkhuizen, Dijkstra, and co-workers have eluci-
dated the first high-resolution 3D structure of a glucansu-
crase protein, GTF180 of Lactobacillus reuteri 180.[120,121]
The structure confirms that, compared to GH-13 a-amylas-
es, the catalytic (b/a)8-barrel domain indeed is circularly per-
muted as was previously proposed.[114] The active site of the
GTF180 protein is very similar to those of GH-13 family
members, suggesting that a very similar reaction mechanism
is responsible for the cleavage of the a-glycosidic bond of
sucrose and the formation of the b-glucosyl–enzyme inter-
mediate. Crystal structures with bound sucrose (donor sub-
strate) and maltose (acceptor substrate), combined with
site-directed mutagenesis experiments, showed that GH-70
glucansucrases possess only one active site and have only
one nucleophilic residue. These results provide a solid basis
for structure-based inhibitor design, and may facilitate the
search for unique specific anticaries drugs. These structures
with ligands also allowed identification of sugar-binding sub-
sites, targets for mutagenesis to generate new enzymes with
improved acceptor substrate reaction specificity and activi-
ty.[121]
Glucansucrase enzymes also catalyze alternative transgly-
cosylation reactions,[33] transferring a glucosyl moiety to suit-
able acceptor substrates (acceptor reaction, see Scheme 6).
Of industrial relevance is the use of dextransucrase for the
production of isomalto oligosaccharides as non-cariogenic
and prebiotic components of beverages and food prepara-
tions.[34, 96,122] Other successful examples include the synthesis
of various oligosaccharides by Leuconostoc mesenteroides al-
ternansucrase,[105] and glucosylation of catechols,[123] salicyl
alcohol, phenol and salicin,[124] flavonoid,[125] epigallocatechin
gallate,[126] arbutin,[127] and l-DOPA[128] by Leuconostoc mes-
enteroides glucansucrase. Seibel et al. evaluated the acceptor
substrate specificity of immobilized glycosyltransferase R
(GTFR, a glucansucrase) of Pseudomonas oralis on sub-
strate microarrays.[129] GTFR glycosylated a broad range of
primary alcohols and amino acid derivatives (peptides),
yielding glycoethers and glycosylated amino acids (pepti-
des). Using tosylated monosaccharides as acceptors, GTFR
performed a highly efficient synthesis of novel branched thi-
ooligosaccharides.[130] Glucosylation of non-saccharide mole-
cules is generally hampered by the poor solubility of these
compounds in water, and the glucansucrase activity loss in
organic solvents. Therefore the activity and stability of glu-
cansucrase enzymes in the presence of water-miscible organ-
ic solvents were studied.[125,131] Only when using such aque-
ous–organic solvents, Leuconostoc mesenteroides glucansu-
crase enzymes catalyzed glucosylation of the non-water solu-
ble flavonoids, luteolin (44% conversion) and myricetin
(49% conversion).[125] Glucosylation considerably increased
the water solubility of these compounds, increasing their po-
tential in pharmacological applications. Also O-glucosides of
phenolic compounds are more soluble in water than their
parent polyphenols, and may find applications in dermocos-
metic, nutritional and therapeutic compositions.[132,133] The
a-glucoside of caffeic acid provides a very promising exam-
ple and is of commercial interest as it regulates key factors
favoring the anti-photo ageing of human skin. Its industrial
production at gram scale and in 75% yield has been report-
ed using a Leuconostoc glucansucrase enzyme.[134]
Unfortunately, glucansucrase productivity in the reaction
with non-carbohydrate acceptors generally remains low (due
to low affinity, inhibition of activity by solvents used, or by
products of the reaction) and will need to be optimized to
become economically viable. Furthermore, it is difficult to
block water completely as the acceptor substrate, meaning
that the yields suffer from a competing hydrolytic reaction
Scheme 6. The polymerization, hydrolysis, and acceptor (with isomaltose
as example) reactions catalyzed by glucansucrase enzymes, resulting in a-
glucan polymer, glucose plus fructose, or oligosaccharide formation, re-
spectively. Glucose, red circle; fructose, green square.
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(Scheme 6). Nevertheless, the reported activities are a prom-
ising starting point for the engineering of glucansucrase
enzyme specificity. To the best of our knowledge, modifying
the acceptor substrate specificity of glucansucrase by means
of site-directed or random mutagenesis has not yet been per-
formed. The recent elucidation of high-resolution crystal
structures of glucansucrase proteins,[121] and the increased in-
sights in the role of acceptor substrate-binding residues,[135]
provide a firm basis for such engineering approaches in
future work. A further drawback is that no thermostable
glucansucrase enzymes are yet available, which limits their
industrial applications. Therefore, engineering of the en-
zymes stability towards high temperatures and the presence
of organic solvents (for applications outside food and cos-
metics industries, that is, in the chemical and pharmaceutical
fields) will have to be performed. The Lactobacillus reuteri
GTFA enzyme is very promising (temperature optimum
50 8C), but does not meet the industrial requirements yet.
Alternatively, novel glucansucrase enzymes are screened for
in nature as well as in (meta)genomic databases.
Glycoside Phosphorylases
Glycoside phosphorylases (GPs) share characteristics with
both glycoside hydrolases and glycosyl transferases.[38,136]
Their physiological role is the degradation of the glycosidic
bond in di- and oligosaccharides using inorganic phosphate,
which results in the production of a glycosyl phosphate and
a saccharide of reduced chain length. Because the phosphate
group can be simply transferred from C1 to C6 by a phos-
phomutase, the product can be metabolized through glycoly-
sis without further activation by a kinase.[137] The phosphoro-
lytic degradation of saccharides is, therefore, more energy-
efficient than their hydrolysis, saving one molecule of ATP.
The name “phosphorylase” is a historic anomaly and the
more accurate “phosphorolase” is almost never used.
From a functional perspective, phosphorylases are thus
very similar to hydrolases, differing only in their use of
phosphate instead of water as nucleophile. This difference
has, however, an important practical consequence, because
the high-energy content of the produced glycosyl phosphate
allows the reactions to be reversed and to be used for syn-
thetic purposes in vitro. In that respect, GPs resemble
Leloir transferases that also employ glycosyl donors activat-
ed by a phosphate group, albeit one that is much larger and
is substituted with a nucleotide.[138] Since a glycosyl phos-
phate is much cheaper than a nucleotide sugar, phosphory-
lases have received a lot of attention as promising biocata-
lysts for the production of oligosaccharides and glycosides.
The donor glucose-1-phosphate, for example, can be readily
produced in large amounts from cheap substrates like
starch, sucrose, or trehalose by the action of various phos-
phorylases.[139–141]
To lower the cost even further, the glycosyl donor can
also be produced in situ by means of so-called “phosphory-
lase coupling”. This strategy is very attractive for the con-
version of a cheap disaccharide, like sucrose, to a more ex-
pensive one like cellobiose. Indeed, the latter compound is
difficult to obtain in pure form through hydrolysis of cellu-
lose, but can be efficiently produced from sucrose by the
combined action of sucrose and cellobiose phosphorylase.[142]
Purification of the product is very simple in that case, as its
much lower solubility compared to that of the substrate su-
crose and of the intermediate a-glucose-1-phosphate allows
cellobiose to be recovered by simple filtration. Phosphory-
lase coupling has also been proposed as a strategy for the
production of trehalose, a non-reducing disaccharide with
important applications in the food industry.[143] Nowadays,
however, it is exclusively produced by a two-step process de-
veloped by the Hayashibara Company, which involves TG
and GH enzymes instead of phosphorylases.[144] Finally, cou-
pling of sucrose and starch phosphorylase has been imple-
mented for the synthesis of amylose with a defined chain
length.[145] This allowed its use as functionalized biopolymer
to replace fossil-based plastics.[146]
An important disadvantage of GPs compared to Leloir
transferases is that their product yields are significantly
lower, with equilibrium constants that are close to one.[38] To
circumvent this problem, the use of glycosyl fluorides as al-
ternative, more reactive donor substrates has been evaluat-
ed. The synthetic reaction catalyzed by cellobiose phosphor-
ylase was found to become completely irreversible in that
case, with the released fluoride being unable to act as nucle-
ophile in the reverse, degradative reaction.[147] This strategy
is reminiscent of the glycosynthase concept in glycosidase
chemistry,[73] but has the additional benefit that the GPs do
not need to be mutated and can thus be used as wild-type
enzymes with only a tenfold reduction in catalytic efficien-
cy.[148]
Another disadvantage of GPs is that their substrate spe-
cificity is rather limited. To date, only about a dozen of
these enzymes have been reported and their donor specifici-
ty is largely restricted to glucose-1-phosphate, in either the
a- or b-configuration.[36] The only known exceptions are chi-
tobiose phosphorylase and the phosphorylases from GH-112
that use a-N-acetylglucosamine-1-phosphate and a-galac-
tose-1-phosphate, respectively, as glycosyl donors.[149,150]
However, we have found that the donor specificity of phos-
phorylases can be expanded towards other glycosyl phos-
phates by means of enzyme engineering. Indeed, directed
evolution of the cellobiose phosphorylase from Cellulomo-
nas uda has resulted in a number of enzyme variants that
also display activity towards a-galactose-1-phosphate.[151,152]
These enzymes are best described as lactose phosphorylases
(LPs), a specificity that has not yet been observed in nature.
The acceptor specificity of phosphorylases is typically
somewhat more relaxed than their donor specificity, and
comprises a range of mono-, di-, and oligosaccharides. Cello-
biose phosphorylase, for example, shows a loose specificity
at the C2- and C5-positions of the acceptor substrate, result-
ing in activity towards glucosamine, mannose, xylose, iso-
maltose, and gentiobiose.[136] In contrast, a strict specificity is
observed at the anomeric position, which must carry a free
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hydroxyl group in the b-configuration.[148] We have found,
however, that this strict requirement can be alleviated by
means of enzyme engineering.[153,154] In this way, enzyme var-
iants could be created for the production of various alkyl or
aryl b-cellobiosides, which have applications as detergents
or as ligands for cellulases.
Non-carbohydrate acceptors have also been reported for
GP enzymes. In that respect, sucrose phosphorylase (SP)
probably is the most interesting biocatalyst. This enzyme
has been found to display activity towards aliphatic, aromat-
ic, and sugar alcohols; ascorbic and kojic acid; furanones;
and catechins.[155] Even a carboxyl group can be used as a
point of attachment, resulting in the synthesis of an ester in-
stead of an ether bond. The latter reactions proceed more
efficiently at low pH, which probably means that a carboxyl
group can only be accepted in protonated form. Under
those conditions, the acyl a-glucosides of formic, acetic, ben-
zoic, and caffeic acid could be produced with the relatively
stable SP enzymes from Bifidobacterium longum[156] and
Streptococcus mutans.[157,158] Interestingly, spontaneous mi-
gration of the acyl group from the C1- to the C2-position
was observed, generating a mixture of compounds in the
final product. Nevertheless, an overall yield of about 80%
could be obtained, at least when high concentrations (ca.
40% w/v) of donor were applied.
Recently, the first commercial application of SP for the
production of glycosides has been implemented by the
German company Bitop AG, based on a process developed
by the group of Nidetzky at TU Graz.[159] They have shown
that the SP from Leuconostoc mesenteroides is able to glyco-
sylate glycerol with exceptional efficiency and regioselectivi-
ty (Scheme 7).[160] By careful optimization of the reaction
conditions, the competing hydrolytic reaction could be com-
pletely suppressed, resulting in near quantitative yields. Fur-
thermore, the glucosyl moiety is exclusively attached to the
C2-OH, whereas the glycosylation of glycerol by cyclodex-
trin glucosyltransferase (CGTase) also involves the C1-
OH.[161] The product is now commercially available under
the trade name Glycoin and is used as moisturizing agent in
cosmetic formulations.
Despite its interesting acceptor specificity, the large-scale
application of sucrose phosphorylase has been hampered by
the low thermostability of the available enzymes. Indeed,
this specificity has not yet been discovered in thermophilic
organisms, in contrast to most other types of phosphorylas-
es.[155] Consequently, SP is typically inactivated in a matter
of minutes at a process temperature of 60 8C. It was recently
shown, however, that the enzyme from Bifidobacterium ado-
lescentis is the exception to the rule, as it stays active for
several hours under these conditions.[162] Its sequence thus
presents the most promising template for the engineering of
the stability and specificity of sucrose phosphorylases for in-
dustrial applications. To that end, the recently developed
high-throughput screening system for SP based on the use
of constitutive promoters will be an indispensable tool.[163]
To increase the operational stability of B. adolescentis SP
at elevated temperatures, several immobilized enzyme for-
mulations have been developed. Covalent attachment of SP
to a Sepabeads enzyme carrier was found to increase the op-
timal temperature for activity by 7 8C,[162] while immobiliza-
tion of SP in the form of a cross-linked enzyme aggregate
(CLEA) increases the optimum by an impressive 17 8C.[164]
More importantly, the latter preparation remained fully
active for more than one week at 60 8C, during which it
could be recycled at least ten times for use in repetitive sub-
strate conversions. This easy and cheap procedure should
result in a cost-efficient exploitation of various glycosylation
reactions catalyzed by SP at the industrial scale.
Because sucrose phosphorylase follows a double displace-
ment mechanism, it can also be applied as a transglycosidase
without the participation of (glycosyl) phosphate
(Scheme 8). In this case, a glucosyl group is transferred di-
rectly from sucrose to an acceptor substrate, similar to the
reaction catalyzed by glucansucrases. Sucrose is not only a
cheaper donor substrate than glucose-1-phosphate, but is
also significantly more reactive. Optimizing the specificity of
SP towards non-carbohydrate acceptors should thus result in
very powerful biocatalysts for the glycosylation of specific
target molecules. To achieve that goal, it will be imperative
Scheme 7. The enzymatic production of glucosyl glycerol with the
enzyme sucrose phosphorylase proceeds with near-quantitative yields.[160]
Scheme 8. The different reactions catalyzed by sucrose phosphorylase. A
covalent glucosyl–enzyme intermediate is formed, from which the gluco-
syl moiety can be transferred to phosphate (phosphorolysis), water (hy-
drolysis), or an alternative acceptor (glycosylation).
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to increase the ratio of transfer over hydrolysis, both of
which are minor side-reactions in the wild-type enzyme, to
minimize the degradation of the glycosylated product.
Challenging Acceptors
Generally, most molecules bearing a hydroxyl group can be
glycosylated using one of the many chemical protocols. Lim-
itations arise when the hydroxyl group is unreactive, sterical-
ly hindered, leads to unwanted reactions such as isomeriza-
tion and elimination, or when other hydroxyl groups of simi-
lar reactivity are present in the molecule. Enzymatic meth-
ods can overcome many of these obstacles, although they
can suffer from other limitations, in particular the poor solu-
bility of the acceptor substrate in water and/or in polar sol-
vents. A number of dogmas exist about the inability of en-
zymes to attack some types of substrates, such as tertiary al-
cohols, thiols, phenols, branched polyols, hydroxyamino
acids, and so forth. However, with the expanding knowledge
of enzymatic reactions, most of these dogmas have fallen. In
the following, we illustrate glycosylation reactions of “diffi-
cult” acceptors to demonstrate the utility and flexibility of
biocatalysis as alternative to chemical synthesis.
Sterically hindered hydroxyl groups (typically tertiary al-
cohols) are often unreactive, also in chemical synthesis.[165]
For reactions with hydrolases (including glycosidases), tert-
butanol has been advocated as a suitable, inert, water-misci-
ble co-solvent to bring hardly soluble substrates into aque-
ous solutions.[43] However, a few studies have shown that
tert-butanol and other tertiary alcohols (e.g., 2-methylbutan-
2-ol) can be enzymatically glycosylated in quite good
yields.[45,166] In turn, substrates carrying more than one acces-
sible hydroxyl group (primary alcoholic) are typically glyco-
sylated at a single site by glycosidases, with subsequent gly-
cosylations leading just to an extension of the first glycosidic
moiety.[167] This phenomenon is useful for the selective mon-
oglycosylation of polyhydroxylated compounds without the
need for protection chemistry (Scheme 9).[168] In contrast,
glycosylation at multiple sites has been reported for trans-
glycosidases and glycoside phosphorylases. Indeed, cyclo-
dextrin glucanotransferase (CGTase) and sucrose phosphor-
ylase (SP) can be used for the synthesis of the diglucoside of
resveratrol and epigallocatechin gallate, respectively
(Scheme 10).[93, 169] Alternatively, diglycosylation of a diva-
lent acceptor, {5-[(allyloxy)methyl]-1,3-phenylene}dimetha-
nol, has been achieved by the sequential action of two gly-
cosidases, that is, b-galactosidase from bovine liver (also ac-
cepting b-Glc), followed by b-galactosidase from E. coli.[170]
A unique example of enzymatic glycosylation has been re-
ported for the unusual acceptor oxime, affording reasonable
yields (15–31%) of its glycoside with the b-galactosidase
from A. oryzae.[171] Another type of difficult substrate for
enzymes is thiols, which are more nucleophilic than alcohols.
Although thiols can act as protein poison causing reductive
inactivation, glycosylation of 1,3-dithiopropane has been
achieved with almond b-glucosidase.[172] A second report on
the glycosylation of thiols by almond b-glucosidase even de-
scribes the production of both O- and S-mercaptoethyl glu-
cosides from mercaptoethanol and glucose, although no
spectral characterization was provided.[173] Many other gly-
cosidases, however, were shown to be inactive towards thio-
alcohols.[174] A modern approach for the enzymatic prepara-
tion of thioglycosides consists in the use of mutant glycosi-
dases, known as thioglycoligases and thioglycosynthases.[175]
Rather surprisingly, proteinogenic hydroxyl amino acids
have been found to be difficult substrates for enzymatic gly-
cosylation.[176] In contrast, N-Boc-protected hydroxylated
amino-acids can be easily glycosylated; the Boc group can
be removed in situ by acidification of the reaction mixture
to pH 4 (Scheme 11). This trick has enabled the synthesis of
Tn antigen (Gal NAc-a-O-Ser/Thr) with a-N-acetylgalacto-
saminidase.[177]
Phenolic hydroxyl groups are usually not accepted by GH
enzymes, but can be glycosylated by TG or GP enzymes, as
illustrated by the above examples of resveratrol and epigal-
locatechin gallate. In fact, CGTase as well as SP have a re-
markably broad acceptor specificity that includes various
Scheme 9. Selective monoglycosylation of polyhydroxylated compounds
without the need for protection chemistry by glycosidases (R=glyco-
sides).[168]
Scheme 10. Synthesis of diglucosides (indicated by “R of resveratrol
(left) and epigallocatechin gallate (right) using cyclodextrin glucanotrans-
ferase (CGTase) and sucrose phosphorylase (SP).[93,169]
Scheme 11. Glycosylation of hydroxylated aminoacids.[177]
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phenolic substrates.[91, 155] In contrast, substrates that have
both an alcoholic and phenolic OH are typically only glyco-
sylated at the alcoholic group by glycosidases, as exemplified
by the glycosylation of kojic acid[178] or pyridoxine.[179] Simi-
larly, carboxyl groups are generally not accepted by GHs,
but have been used by GPs for the production of glycosyl
esters. With SP, for example, the a-glucosides of acetic, ben-
zoic and caffeic acid could be obtained at low pH
values.[156–158]
Finally, some acceptors have so far resisted the glycosyla-
tion attempts by various enzyme classes. This is the case for
geminal hydroxyl groups, which are stable typically in chlo-
ral hydrate or dihydroxymalonic acid. A similar situation
occurs when glycosylating the anomeric hydroxyl group of a
saccharide acceptor, which is actually the hemiacetal of a
geminal diol at C1.[180,181] In this respect, it is interesting to
note that the enzyme will only act on one of the two anom-
ers, although the a- and b-configurations are in equilibrium.
Screening for Improved Biocatalysts
In general, one of the most crucial aspects for the industrial
application of enzymes is their operational stability. Indeed,
biocatalysts need to be sufficiently robust to withstand the
harsh conditions of industrial processes. For glycosylation
reactions in particular, enzymes are required that are both
tolerant to high temperatures and to the presence of organic
(co-)solvents. Nearly all carbohydrate conversions in indus-
try are performed at 55–60 8C, mainly to avoid microbial
contamination. Organic solvents, in turn, are needed to solu-
bilize the hydrophobic compounds that are used as glycosyl
acceptors. Fortunately, the stability of enzymes at high tem-
peratures and in solvents usually coincide, and can thus be
improved simultaneously.[182] Besides stability, the specificity
of the biocatalysts also requires engineering, as most of the
enzymes described here have a strong preference for carbo-
hydrate acceptors.
Obtaining novel biocatalysts
with improved properties can
be achieved by two comple-
mentary approaches: either by
searching in previously unex-
plored natural habitats, or by
the in vitro creation of enzyme
variants. In the former ap-
proach, the development of
metagenomic tools has dramati-
cally increased the natural di-
versity that can be accessed by
bypassing the need to isolate
and cultivate individual micro-
bial species.[183–185] In the latter
approach, directed evolution
has been shown to be an ex-
tremely powerful algorithm that
mimics natural evolution
through random mutagenesis and subsequent selection/
screening of the resulting enzyme libraries.[186–189] In any
case, high-throughput screening typically is the bottleneck
for the identification of improved enzymes in natural as well
as mutant libraries. Indeed, a fast and reliable assay is re-
quired to accurately measure the activity of thousands of
candidate enzymes in a reasonable time span.[190] Although
several assays are available for the detection of GH, TG,
and GP activities, they all have specific disadvantages. For
sucrose phosphorylase, for example, glycosylation reactions
can be detected by measuring either the release of inorganic
phosphate from glucose-1-phosphate as donor[154] or the re-
lease of fructose from sucrose as donor,[162] with the latter
assay also being available for the analysis of TG enzymes
(Scheme 8). Unfortunately, these procedures are destructive
and can therefore only be used for end-point measure-
ments.[191] Evidently, a continuous assay would be much
more valuable as it increases both the accuracy and the
throughput of the screening. Although chromo- and fluoro-
genic substrates are typically well accepted by GHs, these
have not yet been reported for TGs or GPs. Furthermore,
identifying enzyme variants with high activity on chromo-
genic substrates can result in a loss of activity on the natural
donor, as famously stated in the first law of directed evolu-
tion: “you get what you screen for”.
Supramolecular tandem enzyme assays have been recently
introduced by the group of Nau.[192–197] These assays are
based on the molecular recognition of unlabeled substrates
or products by artificial supramolecular macrocyclic recep-
tors. However, these enzyme assays have been developed
for amino acid decarboxylases and not for carbohydrate
modification reactions. In contrast, a supramolecular real-
time fluorescent assay has been introduced for sucrose phos-
phorylase and phosphoglucomutase by Schiller in collabora-
tion with the Singaram group.[198] In the case of SP, this non-
destructive assay makes use of a selective carbohydrate
sensing system that detects the unlabeled enzymatic product
fructose (Scheme 12). It is perfectly suited for the screening
Scheme 12. Enzyme assay for sucrose phosphorylase with selective detection of the unlabeled product fructose
by N,N’-bis-(benzyl-2-boronic acid)-4,4’-bipyridinium dibromide (4,4’-o-BBV). Adapted and reprinted from
reference [198] with permission from Elsevier.
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of glycosylation reactions with sucrose as donor (e.g., su-
crose phosphorylase as well as glucansucrase), because fruc-
tose is always released as product (Scheme 6 and 8). The
sensing system is composed of commercially available 8-hy-
droxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS) as
the reporter unit and N,N’-bis-(benzyl-2-boronic acid)-4,4’-
bipyridinium dibromide (4,4’-o-BBV) as selective receptor
for fructose. Sucrose and glucose-1-phosphate do not show
any significant binding affinity to 4,4’-o-BBV.[198,199] The sac-
charide-sensing system was originally introduced by Singar-
am and Wessling for continuous-glucose sensing. Progress in
this endeavor is documented in a series of publications de-
tailing the chemistry of the system and the development of
sensors based on immobilization of the sensing components
in hydrogels.[199–208] The sensor will be commercialized for
continuous glucose monitoring in intensive care units.[209] In
collaboration with the laboratory of Schiller[41,210] the sensing
system was used to go beyond continuous glucose sens-
ing,[210] such as multivariate analysis,[199,202] hydrogels in mul-
tiwell plates,[211] and enzyme assays.[198]
The proposed signaling mechanism involves ground-state
complex formation between the anionic fluorescent dye and
the cationic receptor (a boronic acid based bipyridinium
salt) that facilitates electron transfer from the dye to the bi-
pyridinium salt. This results in a static quenching of the fluo-
rescence intensity of the dye. When a reducing saccharide is
added to the ground-state complex, the boronic acids are
converted into anionic boronate esters, partially neutralizing
the net charge of the cationic viologen. This reduces the
quenching efficacy and increases the fluorescence intensity.
The change in fluorescence can be converted into product
concentration, allowing initial reaction velocities and Mi-
chaelis–Menten kinetics to be calculated. The assay can be
carried out in multiwell plate formats, making it suitable for
high-throughput screening.
In contrast to a standard indicator displacement assay
(IDA), formulated by Anslyn et al.,[212,213] the indicator in
the Singaram system is displaced by the analyte from a so-
called “allosteric interaction”.[41,210] This means that the ana-
lyte does not compete at the same binding site with the indi-
cator. It binds at another site (allos stereos Greek “other
object”), thereby inducing a decrease in the affinity of the
indicator for the receptor. This new type of assay can be
called an “allosteric indicator displacement assay” (AIDA).
Recently, the group of Schiller combined fluorescence corre-
lation spectroscopy with an AIDA saccharide probe to
detect fructose at a nanomolar dye concentration. Digital
analysis revealed a complementary implication/notimplica-
tion logic function.[214]
It is important to note that the AIDA enzyme assay was
also used recently by the group of Seibel for sucrose isomer-
ases. An isomaltulose synthase was redesigned to an isome-
lezitose synthase by site-directed mutagenesis. The enzyme
assay gave important information as to how much of the
substrate sucrose was hydrolyzed to glucose and fructose in
the side reaction.[215]
Conclusions and Perspectives
To circumvent the problems associated with the chemical
synthesis of glycosides, several classes of carbohydrate-
active enzymes can be recruited, but all of them have their
own advantages and disadvantages. On the one hand, glyco-
side hydrolases and “Leloir” glycosyl transferases offer a
very wide range of specificities, but their use is hampered by
low yields and the high price of the glycosyl donors, respec-
tively. On the other hand, transglycosidases and glycoside
phosphorylases comprise fewer specificities but are active
with low-cost donor substrates that generate moderate to
good yields. In any case, a biocatalysts productivity may be
further improved by enzyme engineering to increase the
commercial potential of their glycosylation reactions. In that
respect, the recent elucidation of a high-resolution 3D struc-
ture of the GTF180 glucansucrase[120,121] represents a major
breakthrough, since it will allow the use of more rational en-
gineering strategies.
A prospective approach to the development of new glyco-
sylation reactions catalyzed by GH, TG, and GP enzymes is
to select specificities that transfer a glycosyl group from
cheap and readily available donor substrates (e.g., sucrose)
to a range of acceptor compounds. Here, the glycosylation
of small organic molecules, like flavonoids, alkaloids, and
steroids, offers a yet-to-be-explored reservoir of applica-
tions. For that goal, new enzymes with high activity and sta-
bility could probably be identified in either natural environ-
ments or mutant libraries, using the novel fluorescent
probes as tools for high-throughput screening. Collaboration
between academia and industry would then allow the evalu-
ation of the economic potential of selected reactions in
pilot-scale processes. In that way, several new glycosides
may become commercially available for application in the
food, feed, chemical, cosmetic, and pharmaceutical indus-
tries.
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